ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 233 filers reported holding ROYALTY PHARMA PLC in Q2 2021. The put-call ratio across all filers is 1.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,710,000 | -11.7% | 1,500,000 | 0.0% | 0.63% | -13.6% |
| Q2 2023 | $46,110,000 | -14.7% | 1,500,000 | 0.0% | 0.73% | +15.8% |
| Q1 2023 | $54,045,000 | -8.8% | 1,500,000 | 0.0% | 0.63% | -20.0% |
| Q4 2022 | $59,280,000 | -1.6% | 1,500,000 | 0.0% | 0.78% | +10.6% |
| Q3 2022 | $60,270,000 | -4.4% | 1,500,000 | 0.0% | 0.71% | -13.7% |
| Q2 2022 | $63,060,000 | +7.9% | 1,500,000 | 0.0% | 0.82% | +54.1% |
| Q1 2022 | $58,440,000 | -2.2% | 1,500,000 | 0.0% | 0.53% | +15.8% |
| Q4 2021 | $59,775,000 | +10.3% | 1,500,000 | 0.0% | 0.46% | +45.4% |
| Q3 2021 | $54,210,000 | -11.8% | 1,500,000 | 0.0% | 0.32% | -27.1% |
| Q2 2021 | $61,485,000 | -6.0% | 1,500,000 | 0.0% | 0.44% | -43.2% |
| Q1 2021 | $65,430,000 | -12.8% | 1,500,000 | 0.0% | 0.77% | -21.5% |
| Q4 2020 | $75,075,000 | +19.0% | 1,500,000 | 0.0% | 0.98% | +0.2% |
| Q3 2020 | $63,105,000 | -13.3% | 1,500,000 | 0.0% | 0.97% | -55.4% |
| Q2 2020 | $72,825,000 | – | 1,500,000 | – | 2.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |